ClinicalTrials.Veeva

Menu

Diabetes and Partnership: Evaluation of a Diabetes Education Module (PRIMO_Partner)

F

Forschungsinstitut der Diabetes Akademie Mergentheim

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Behavioral: Education - Diabetes and Partnership

Study type

Interventional

Funder types

Other

Identifiers

NCT02076568
NH022014_4

Details and patient eligibility

About

This study is a multi-center, randomized prospective trial with a 6-month follow up. A newly developed treatment and education module will be tested compared to a waiting-list control group. The module covers the topic "diabetes and partnership". Primary outcome variable is diabetes-specific empowerment regarding diabetes and partnership. Secondary outcome variables are: diabetes-related distress, health-related quality of life, depressive symptoms, self-care behavior, and glycemic control.

Full description

The module consists of one lesson (duration: 90 minutes). The module is derived from the empowerment approach and is based on the previously evaluated education and treatment program for type 1 diabetes: PRIMAS (NCT01220557). The module is designed as a group session held by a trained diabetes educator. Patients are randomized either to the immediate participation in the module or to the control group. Control group is a waiting-list control group. Patients in this waiting-list control group get the education after the completion of the 6-month follow-up.

Enrollment

201 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Intensive insulin treatment
  • specific interest in "Diabetes and Partnership"
  • wish to participate in group education
  • informed consent
  • fluent in reading and speaking German language

Exclusion criteria

  • diabetes duration < 4 week
  • severe organic disease (e.g. terminal renal disease, cancer with poor prognosis)
  • current treatment of a mental disease
  • cognitive impairment
  • dementia
  • pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

201 participants in 2 patient groups

Education - Diabetes and Partnership
Experimental group
Description:
Patients randomized to this arm, will participate immediately in the education module "Diabetes and Partnership"
Treatment:
Behavioral: Education - Diabetes and Partnership
Waiting-list control group
No Intervention group
Description:
Patients in the control group will get the education with the education module after completion of the 6-month follow-up

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems